Naxitamab, CAS 1879925-92-4

Product Description: Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting the disialoganglioside GD2. Naxitamab can be used in research of neuroblastoma, osteosarcoma and other GD2-positive cancers[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Cheung NK, et, al. Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo. Oncoimmunology. 2012 Jul 1;1(4):477-486./[2]Markham A. Naxitamab: First Approval. Drugs. 2021 Feb;81(2):291-296.

CAS Number: 1879925-92-4

Molecular Weight: N/A

Compound Purity: 98.13

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99206-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99206-5
• Green Labware: Nein
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK